Cancer Plan Has Big Goal; Boosting Advanced-Care Planning; Elephant Genes for Cancer

[MEDPAGE TODAY]( Oncology Update Friday, April 07, 2023 [Cancer Plan Has Big Goal; Boosting Advanced-Care Planning; Elephant Genes for Cancer]( [Leading Causes of Death Hit Childhood Cancer Survivors Earlier]( [CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastoma]( [Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosis]( ADVERTISEMENT Exclusives & Features [Why Doctors Shouldn't Be 'Freaked Out' About AI, According to ChatGPT]( [CMS Cracks Down on Medicare Advantage Marketing, Prior Auth Practices]( [ChatGPT May Help Patients Better Understand Cirrhosis, Liver Cancer]( [Olaparib: Drug to treat inherited cancers offered on NHS in England and Wales]( Olaparib specifically targets cancers caused by faulty genes, like BRCA, and could be life-saving. [READ MORE]( [Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial.]( PURPOSE: Resectable non-small-cell lung cancer (NSCLC) with a high probability of mediastinal nodal involvement requires mediastinal staging by endosonography and, in the absence of nodal metastases,... [READ MORE]( [ChristianaCare research may result in 'more precise' advanced colorectal cancer treatment]( Researchers at ChristianaCare's Cawley Center for Translational Cancer Research in Newark, Del., made a discovery that could lead to a more precise treatment for advanced colorectal cancer. [READ MORE]( [Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).]( PURPOSE: Consensus molecular subtypes (CMSs) were evaluated as prognostic and predictive biomarkers of patients with RAS wild-type metastatic colorectal cancer (mCRC) receiving fluorouracil and... [READ MORE]( [Wiltshire Air Ambulance pilot Rob Collingwood dies from cancer]( Rob Collingwood, who died from cancer aged 42, "loved" working for the charity, bosses say. [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-04-07&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011